The treatment of Brady Arrhythmia & Leukoplakia with vitamins

Brady Arrhythmia and Leukoplakia: Mitamins custom make quality formulas for the treatment of Brady Arrhythmia & Leukoplakia with vitamins. A Brady Arrhythmia & Leukoplakia formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Brady Arrhythmia and Leukoplakia

  • Amount Per Serving
    % DV
    Vitamin A
    2500
    IU
    50%
    Vitamin C
    100
    mg
    167%
    Vitamin E
    200
    IU
    667%
    Calcium
    200
    mg
    20%
    Magnesium
    100
    mg
    25%
    CoQ-10
    30
    mg
    *
  • Amount Per Serving
    % DV
    Lycopene
    500
    mcg
    *
    Garlic Extract
    100
    mg
    *
    Grape Seed Extract
    50
    mg
    *
    Green Tea Extract
    100
    mg
    *
    Hawthorn Extract
    250
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Brady Arrhythmia and Leukoplakia
Serving Size:4-5

Brady Arrhythmia and Leukoplakia Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Alnylam And Medtronic Advance Collaboration On Drug-Device Combinations With RNAi Therapeutics For CNS Diseases
Medtronic, Inc., (NYSE: MDT) and Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced that the companies are advancing their collaboration initiated in February, 2005, following positive pre-clinical data generated under the initial joint technology development phase of the program. Under the terms of the agreement, Alnylam and Medtronic will focus on developing a drug-device combination for the treatment of Huntington's disease.
BIO Announces Venue For 2008 World Congress On Industrial Biotechnology And BioProcessing, USA
The Biotechnology Industry Organization (BIO) will host the 2008 World Congress on Industrial Biotechnology and BioProcessing on April 27-30 at the Hilton Chicago in Chicago, Ill. Leaders from the biotechnology, chemical and agricultural industries will join with government officials, investors and academics for the fifth annual conference. The conference Web site can be accessed here.
This information concerning the support of Brady Arrhythmia and Leukoplakia treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments